Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atypon is a leading provider of software solutions and publishing technologies specifically designed for the scholarly and scientific publishing industry. Its flagship platform, Literatum, hosts a significant portion of the world's English-language scholarly content, providing publishers with tools for content management, discovery, and monetization. While not a drug developer, Atypon is a critical infrastructure provider for the life sciences and healthcare sectors by enabling the dissemination of peer-reviewed medical and scientific research. The company was acquired by John Wiley & Sons in 2016 and continues to operate as a key technology division within the global publishing giant.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atypon.